会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • PROCESS TO PRODUCE FIBRILLAR PROTEINS AND METHOD OF TREATMENT USING FIBRILLAR PROTEINS
    • 生产纤维蛋白的方法和使用纤维蛋白的治疗方法
    • US20120316117A1
    • 2012-12-13
    • US13572652
    • 2012-08-12
    • Shu-Mei LiangChun-Yung HuangChi-Ming Liang
    • Shu-Mei LiangChun-Yung HuangChi-Ming Liang
    • A61K38/38A61P35/00
    • A61K31/7088A61K38/162A61K38/38A61K38/39A61K39/39A61K2039/55516
    • A method for inhibiting survival of cancer cells in a subject is disclosed. The method comprises administering to a subject in need thereof a therapeutically effective amount of fibrillar albumin. The preparation of the fibrillar albumin comprises: (i) forming a solution comprising an isolated and/or purified globular albumin; (ii) adding a detergent to the solution containing the isolated and/or purified globular albumin, wherein the detergent is one selected from the group consisting of sodium dodecyl sulfate (SDS) and n-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; (iii) applying the solution to a molecular sizing column with a pore size that permits separation of a protein with a molecular weight of at least about 70 kDa so as to promote column-induced formation of the fibrillar albumin from the isolated and/or purified globular albumin; and (iv) eluting the fibrillar albumin from the column, wherein the eluted albumin has a fibrillar structure.
    • 公开了抑制受试者中癌细胞存活的方法。 该方法包括向有需要的受试者施用治疗有效量的原纤维白蛋白。 纤维状白蛋白的制备包括:(i)形成包含分离和/或纯化的球状白蛋白的溶液; (ii)向含有分离和/或纯化的球状白蛋白的溶液中加入洗涤剂,其中洗涤剂选自十二烷基硫酸钠(SDS)和正十四烷基-N,N-二甲基-3-氨基 -1-丙磺酸盐; (iii)将溶液施加到具有允许分离至少约70kDa的分子量的蛋白质的孔径的分子筛分柱,以便促进来自分离和/或纯化的柱状诱导的纤维状白蛋白的形成 球状白蛋白 和(iv)从柱中洗脱纤维状白蛋白,其中洗脱的白蛋白具有纤维状结构。
    • 5. 发明授权
    • Process to produce fibrillar proteins
    • 生产纤维蛋白的方法
    • US08268974B2
    • 2012-09-18
    • US12082634
    • 2008-04-11
    • Shu-Mei LiangChun-Yung HuangYen-Po ChenChi-Ming Liang
    • Shu-Mei LiangChun-Yung HuangYen-Po ChenChi-Ming Liang
    • A61K38/00A61K45/00C07K1/00C07K14/00
    • A61K31/7088A61K38/162A61K38/38A61K38/39A61K39/39A61K2039/55516
    • A method for changing a globular protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a detergent to the solution containing the globular protein, applying the solution to a molecular sizing column with a pore size of at least 70 kDa and eluting with a solution containing detergent. A method for changing an unfolded protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a urea to the solution to unfold the globular protein, applying the solution to a molecular sizing column and eluting with a solution containing detergent. A method for treating cancer comprising the steps of providing a protein, changing the protein into a fibrillar structure, and administering a therapeutically effective amount of the fibrillar structure protein to a patient in need thereof. A method for producing a vaccine adjuvant or antigen adjuvant comprising the steps of providing a protein, and changing the protein into a fibrillar structure.
    • 一种将球状蛋白结构变为纤维状蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向含有球状蛋白质的溶液中加入洗涤剂,将溶液施加到孔径至少为70kDa的分子筛分柱上,并用 含有洗涤剂的溶液。 将展开的蛋白质结构改变成纤维蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向溶液中加入尿素以展开球状蛋白质,将溶液施加到分子筛分柱上并用含有洗涤剂的溶液洗脱。 一种治疗癌症的方法,包括提供蛋白质,将蛋白质改变成纤维结构,以及向有需要的患者施用治疗有效量的纤维结构蛋白的步骤。 一种用于生产疫苗佐剂或抗原佐剂的方法,包括提供蛋白质并将蛋白质变成纤维结构的步骤。
    • 8. 发明授权
    • Fibrillar albumin for use in inhibiting cancer growth
    • 用于抑制癌症生长的纤维白蛋白
    • US08685923B2
    • 2014-04-01
    • US13572652
    • 2012-08-12
    • Shu-Mei LiangChun-Yung HuangChi-Ming Liang
    • Shu-Mei LiangChun-Yung HuangChi-Ming Liang
    • A61K38/38C07K14/76C07K1/16
    • A61K31/7088A61K38/162A61K38/38A61K38/39A61K39/39A61K2039/55516
    • A method for inhibiting survival of cancer cells in a subject is disclosed. The method comprises administering to a subject in need thereof a therapeutically effective amount of fibrillar albumin. The preparation of the fibrillar albumin comprises: (i) forming a solution comprising an isolated and/or purified globular albumin; (ii) adding a detergent to the solution containing the isolated and/or purified globular albumin, wherein the detergent is one selected from the group consisting of sodium dodecyl sulfate (SDS) and n-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; (iii) applying the solution to a molecular sizing column with a pore size that permits separation of a protein with a molecular weight of at least about 70 kDa so as to promote column-induced formation of the fibrillar albumin from the isolated and/or purified globular albumin; and (iv) eluting the fibrillar albumin from the column, wherein the eluted albumin has a fibrillar structure.
    • 公开了抑制受试者中癌细胞存活的方法。 该方法包括向有需要的受试者施用治疗有效量的原纤维白蛋白。 纤维状白蛋白的制备包括:(i)形成包含分离和/或纯化的球状白蛋白的溶液; (ii)向含有分离和/或纯化的球状白蛋白的溶液中加入洗涤剂,其中洗涤剂选自十二烷基硫酸钠(SDS)和正十四烷基-N,N-二甲基-3-氨基 -1-丙磺酸盐; (iii)将溶液施加到具有允许分离至少约70kDa的分子量的蛋白质的孔径的分子筛分柱,以便促进来自分离和/或纯化的柱状诱导的纤维状白蛋白的形成 球状白蛋白 和(iv)从柱中洗脱纤维状白蛋白,其中洗脱的白蛋白具有纤维状结构。